Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 July 2020: Lab/In Vitro Research

Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1

Lun Luo ABE* , Chuan Chen ACD , Haiyong He DFG , Meiqin Cai BCFG , Cong Ling BCE

DOI: 10.12659/MSM.922659

Med Sci Monit 2020; 26:e922659

Figure 5 AKR1B1 interacted with NORAD. (A) The interplay between NORAD and AKR1B1 was detected by RIP assay. The expression of AKR1B1 in glioma cell lines (GSC11, M059J, U251, and T98G) was measured by (B) western blotting and (C) RT-qPCR, respectively. Three independent experiments were carried out (n=3). ** P<0.01, *** P<0.001 versus A735. The level of AKR1B1 in U251 cells was examined using (D) western blotting and (E) RT-qPCR after transfection with si-NORAD-2. All experiments were repeated 3 times independently (n=3). ** P<0.01 versus si-NC. NORAD – noncoding RNA activated by DNA damage; RIP – RNA-binding protein immunoprecipitation; RT-qPCR – reverse transcription-quantitative polymerase chain reaction; si-NORAD – small interfering RNAs (siRNAs) against NORAD; si-NC – negative control for NORAD siRNA.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750